BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 19367269)

  • 21. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.
    Hoving MA; van Raak EP; Spincemaille GH; van Kranen-Mastenbroek VH; van Kleef M; Gorter JW; Vles JS;
    Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural course of abdominal pain in chronic pancreatitis with intermittent (type A) pain after conservative treatment.
    Pongprasobchai S; Manatsathit S
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S43-8. PubMed ID: 19562985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes after endoscopic minor papilla therapy in symptomatic patients with pancreas divisum.
    Borak GD; Romagnuolo J; Alsolaiman M; Holt EW; Cotton PB
    Pancreas; 2009 Nov; 38(8):903-6. PubMed ID: 19672208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total pancreatectomy for the treatment of chronic pancreatitis: indications, outcomes, and recommendations.
    Behrman SW; Mulloy M
    Am Surg; 2006 Apr; 72(4):297-302. PubMed ID: 16676850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis.
    Alexakis N; Connor S; Ghaneh P; Raraty M; Lombard M; Smart H; Evans J; Hughes M; Garvey CJ; Goulden M; Parker C; Sutton R; Neoptolemos JP
    Surgery; 2004 Sep; 136(3):600-8. PubMed ID: 15349108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; PittalĂ  G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intrathecal administration of morphine and bupivacaine in the treatment of severe pain in chronic pancreatitis].
    Verheijen R; Slappendel R; Jansen JB; Crul BJ; van Dongen RT
    Ned Tijdschr Geneeskd; 1996 Jul; 140(27):1410-2. PubMed ID: 8766685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study.
    Buscher HC; Wilder-Smith OH; van Goor H
    Eur J Pain; 2006 May; 10(4):363-70. PubMed ID: 16087373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited effect of thoracoscopic splanchnicectomy in the treatment of severe chronic pancreatitis pain: a prospective long-term analysis of 75 cases.
    Buscher HC; Schipper EE; Wilder-Smith OH; Jansen JB; van Goor H
    Surgery; 2008 Jun; 143(6):715-22. PubMed ID: 18549887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain.
    Hamza M; Doleys D; Wells M; Weisbein J; Hoff J; Martin M; Soteropoulos C; Barreto J; Deschner S; Ketchum J
    Pain Med; 2012 Oct; 13(10):1304-13. PubMed ID: 22845187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe peripheral edema during an outpatient continuous epidural morphine infusion trial in a patient with failed back surgery syndrome.
    Ruan X; Tadia R; Couch JP; Ruan J; Chiravuri S
    Pain Physician; 2008; 11(3):363-7. PubMed ID: 18523508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sacral nerve stimulation for voiding dysfunction: One institution's 11-year experience.
    Sutherland SE; Lavers A; Carlson A; Holtz C; Kesha J; Siegel SW
    Neurourol Urodyn; 2007; 26(1):19-28; discussion 36. PubMed ID: 17078071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized clinical trial of an implantable drug delivery system.
    Davis MP; Walsh D; Lagman R; LeGrand SB
    J Clin Oncol; 2003 Jul; 21(14):2800-1; author reply 2802-3. PubMed ID: 12860958
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival.
    Ripamonti C; Brunelli C
    J Clin Oncol; 2003 Jul; 21(14):2801-2; author reply 2802-3. PubMed ID: 12860959
    [No Abstract]   [Full Text] [Related]  

  • 35. Patient-controlled analgesia in chronic pain patients: experience with a new device designed to be used with implanted programmable pumps.
    Ilias W; le Polain B; Buchser E; Demartini L;
    Pain Pract; 2008; 8(3):164-70. PubMed ID: 18384501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion.
    Dario A; Scamoni C; Bono G; Ghezzi A; Zaffaroni M
    Funct Neurol; 2001; 16(4):311-5. PubMed ID: 11853321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duodenum- and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis.
    Alexakis N; Ghaneh P; Connor S; Raraty M; Sutton R; Neoptolemos JP
    Br J Surg; 2003 Nov; 90(11):1401-8. PubMed ID: 14598422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of pain in chronic pancreatitis: clinical implications from a surgical perspective.
    Tsiotou AG; Sakorafas GH
    Int Surg; 2000; 85(4):291-6. PubMed ID: 11589594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management.
    Zin CS; Nissen LM; O'Callaghan JP; Moore BJ; Smith MT
    Pain Med; 2010 Apr; 11(4):550-61. PubMed ID: 20202139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.